Pioneering 3D Human Tissues for Drug Discovery

News

Mar 19 | 2025

Organovo Announces Reverse Stock Split

Mar 06 | 2025

Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises

Feb 25 | 2025

Organovo’s FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company